Sponsored by:

Molecular Imaging: Page 191

Gamma Medica wins NY LumaGem installation
By AuntMinnie.com staff writers
Molecular imaging developer Gamma Medica has won a contract with Mercy Medical Center in Rockville Centre, NY, for its LumaGem molecular breast imaging system.
March 23, 2017
ImaginAb names Coombs as CEO
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has appointed Martyn Coombs to the post of CEO. He replaces Benjamin Chen, PhD, who was named CEO in January 2016.
March 22, 2017
Holst joins NorthStar Medical
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes announced it has named Lisa Holst as vice president of sales and marketing.
March 22, 2017
Worldwide SPECT market expected to top $1.5B by 2021
By AuntMinnie.com staff writers
The global SPECT market is projected to grow to $1.5 billion U.S. (1.4 billion euros) by 2021, at a compound annual growth rate of more than 5% during the forecast period, according to market research firm Technavio.
March 20, 2017
North American radiopharma market could spike
By AuntMinnie.com staff writers
The North American radiopharmaceuticals market could double from more than $2 billion in 2015 to $4 billion by 2026, according to market research report firm ReportBuyer.
March 19, 2017
Lantheus plans secondary offering of 3M shares
By AuntMinnie.com staff writers
Lantheus Holdings said that certain of its existing stockholders will sell 3 million shares of its common stock in a public secondary offering.
March 13, 2017
MRI debunks 'liberation therapy' | PET/CT guides pediatric cancer biopsy | 8 ways to win turf battles
By Brian Casey
March 8, 2017
Piramal partner gets Canadian approval for Neuraceq
By AuntMinnie.com staff writers
Piramal Imaging's partner in Canada has received marketing authorization from Health Canada to begin commercial production and distribution of its Neuraceq radiotracer for diagnosing Alzheimer's disease.
March 7, 2017
Novel PET tracer aids recurrent prostate cancer patients
By Wayne Forrest
A study in the March issue of the Journal of Nuclear Medicine is touting the PET radiotracer fluciclovine F-18 for its ability to guide and monitor targeted treatment for recurrent prostate cancer.
March 7, 2017
2017 03 07 16 49 20 479 Fluciclovine Pet Jnm 20170307235006
FDG-PET/CT can direct biopsies for pediatric cancer
By Wayne Forrest
FDG-PET/CT can play a valuable role in directing image-guided biopsies of pediatric cancer patients, given its ability to detect and discern between malignant and benign regions, according to a study by a group from Saudi Arabia and Canada published in the March issue of the American Journal of Roentgenology.
March 7, 2017
2017 03 06 11 31 38 851 Coronal Pet Ct Mol Insider Image 200
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
March 5, 2017
New PET tracer shows promise for atherosclerosis
By AuntMinnie.com staff writers
European researchers have developed a PET tracer that has shown the ability to quickly and noninvasively identify life-threatening atherosclerotic plaques, according to a study published in the March issue of the Journal of Nuclear Medicine.
March 1, 2017
Previous Page
Page 191 of 621
Next Page